<DOC>
	<DOCNO>NCT02601235</DOCNO>
	<brief_summary>Prospective , randomize , open label , parallel , multicenter clinical study , control active comparator ( 0.05 % Oxymetazoline Hydrochloride ) . The investigator hypothesis pediatric Naridrin® nasal solution superior 0.05 % Oxymetazoline Hydrochloride improve nasal congestion . Participants age 10-17 year clinical diagnosis nasal congestion allergic inflammatory origin least one nostril due rhinitis rhinopharyngitis include trial .</brief_summary>
	<brief_title>Clinical Study Evaluating Efficacy Safety Pediatric Drugs Improving Nasal Congestion .</brief_title>
	<detailed_description>Prospective , randomize , open label , parallel , multicenter clinical study , control active comparator ( 0.05 % Oxymetazoline Hydrochloride ) . The investigator hypothesis pediatric Naridrin® nasal solution superior 0.05 % Oxymetazoline Hydrochloride improve nasal congestion . Participants age 10-17 year clinical diagnosis nasal congestion allergic inflammatory origin least one nostril due rhinitis rhinopharyngitis include trial . The treatment period 2 day .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Pyrilamine</mesh_term>
	<mesh_term>Naphazoline</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<criteria>Participants age 1017 year clinical symptom nasal congestion inflammatory allergic origin least one nostril due rhinitis rhinopharyngitis ( cold flu ) ; Participants agree participate study sign date informed consent form duplicate ; Participants whose mother , father / legal guardian accordance study purpose procedure , sign date two copy IC , willing adhere treatment attend schedule appointment study ; Participants clinical symptom nasal congestion least one nostril diagnostic method use Glatzel mirror ( nasal flow less 2 cm least one nostril ) ; B negative urine HCG female participant childbearing potential . Participation clinical trial last 12 month precede study ( CNS Resolution 251 August 7 , 1997 , Part III , subsection J ) , unless investigator considers may direct benefit ; Total obstruction one nostrils etiologies inflammatory allergic ; Infectious bacterial disease ( clinically diagnose ) ; Participants treat antibiotic possible antibiotic use due another medical condition ; Use intranasal corticosteroid ( 7 day prior study ) systemic ( 15 day prior study ) , regard plasma halflife drug ; Use decongestant antihistamine ( intranasal systemic ) 03 day prior study ; Use inhale drug ( except nasal moisturizers saline ) treatment immunosuppressant week study ; Participants septum deviation grade II III , nasal polyp , severe turbinate hypertrophy , adenoid hypertrophy , determine factor nasal obstruction ; Hyperthyroidism hypertension know hypersensitivity component study drug ; History transphenoidal hypophysectomy surgery oronasal exposure duramater ; Exclusive mouthbreathers ; Participants chronic drug treatment allergy ( eg vaccine allergy , cromolyn ) ; History alcohol abuse / drug 3 month study ; Smokers Teens pregnant , breastfeed plan become pregnant , adolescent childbearing potential use reliable method contraception Presence medical psychological condition , discretion investigator , may prevent individual participating study .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>rhinitis</keyword>
</DOC>